DK0925789T4 - Anvendelse af azithromycin ved topisk behandling af öjeninfektioner - Google Patents

Anvendelse af azithromycin ved topisk behandling af öjeninfektioner

Info

Publication number
DK0925789T4
DK0925789T4 DK98309274T DK98309274T DK0925789T4 DK 0925789 T4 DK0925789 T4 DK 0925789T4 DK 98309274 T DK98309274 T DK 98309274T DK 98309274 T DK98309274 T DK 98309274T DK 0925789 T4 DK0925789 T4 DK 0925789T4
Authority
DK
Denmark
Prior art keywords
azithromycin
topical treatment
eye infections
treatment
infections
Prior art date
Application number
DK98309274T
Other languages
English (en)
Other versions
DK0925789T3 (da
Inventor
Imran Ahmed
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0925789(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK0925789T3 publication Critical patent/DK0925789T3/da
Publication of DK0925789T4 publication Critical patent/DK0925789T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK98309274T 1997-12-02 1998-11-12 Anvendelse af azithromycin ved topisk behandling af öjeninfektioner DK0925789T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02

Publications (2)

Publication Number Publication Date
DK0925789T3 DK0925789T3 (da) 2004-10-25
DK0925789T4 true DK0925789T4 (da) 2009-07-13

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98309274T DK0925789T4 (da) 1997-12-02 1998-11-12 Anvendelse af azithromycin ved topisk behandling af öjeninfektioner

Country Status (11)

Country Link
EP (1) EP0925789B2 (da)
JP (1) JPH11240838A (da)
AT (1) ATE271390T1 (da)
BR (1) BR9805318A (da)
CA (1) CA2254682C (da)
CY (1) CY1105482T1 (da)
DE (1) DE69825128T3 (da)
DK (1) DK0925789T4 (da)
ES (1) ES2221127T5 (da)
MX (1) MX232591B (da)
PT (1) PT925789E (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
EP1563850A3 (en) * 2000-02-23 2008-02-20 Pfizer Products Inc. Method of increasing the bioavailability and tissue penetration of azithromycin
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
FR2823441B1 (fr) 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1671979B1 (en) 2001-05-22 2008-08-13 Pfizer Products Inc. New Cristal Form of Azithromycin
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513145A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
EP1782816B1 (en) 2004-07-02 2011-10-19 Wakamoto Pharmaceutical Co., Ltd. Water-based medicinal composition containing azithromycin and method of preparing the same
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
CA2173109A1 (en) * 1993-10-01 1995-04-13 Kenneth Shyer Kornman Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) * 1994-12-19 1996-07-10 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
JP4330175B2 (ja) † 1995-06-07 2009-09-16 デュレクト コーポレイション 高粘度液体による制御された送達系

Also Published As

Publication number Publication date
CA2254682C (en) 2003-07-08
PT925789E (pt) 2004-10-29
DE69825128T3 (de) 2010-05-06
ATE271390T1 (de) 2004-08-15
BR9805318A (pt) 2000-04-11
EP0925789B1 (en) 2004-07-21
DE69825128D1 (de) 2004-08-26
MX232591B (es) 2005-12-02
CA2254682A1 (en) 1999-06-02
CY1105482T1 (el) 2010-04-28
EP0925789B2 (en) 2009-06-17
JPH11240838A (ja) 1999-09-07
ES2221127T3 (es) 2004-12-16
DE69825128T2 (de) 2005-07-28
ES2221127T5 (es) 2009-11-10
EP0925789A1 (en) 1999-06-30
DK0925789T3 (da) 2004-10-25

Similar Documents

Publication Publication Date Title
DK0925789T3 (da) Anvendelse af azithromycin ved topisk behandling af öjeninfektioner
IT1313610B1 (it) Processo per la preparazione di formulazioni acquose per uso oftalmico
DE69309188T2 (de) Zusammensetzung für Okularlensen
PE14199A1 (es) Agonistas de 5-ht1f
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
BR9710993A (pt) Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als)
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
DK1384478T3 (da) Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
BR0015257A (pt) Ente de contato útil para evitar olho seco
DK0788513T3 (da) Anvendelse af bindingsmidler for CD23 i behandlingen af atoimmune sygdomme
DE69917651D1 (de) Hornhautlinse
DK0869949T3 (da) Benzoxaziner som antimikrobielle midler
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
DE69520998T2 (de) Faserbehandlungszusammensetzungen
FR2731007B1 (fr) Composition de polyorganosiloxanes reticulables
ID25478A (id) Agonis 5-ht1f
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
DE69307740T2 (de) Zusammensetzung für Okularlinsen
BR9813634A (pt) "abridores de canal de potássio"
DE69620313D1 (de) Als antimikrobielles Mittel verwendbare Zusammensetzung
BR9610382A (pt) Composição de tratamento do cableo
DE60003074D1 (de) Fusidinsäure-derivate
DK1445641T3 (da) Okulære linser
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose